Related Experiment Videos
Mediastinal irradiation for chronic lymphocytic leukemia
The American Journal of Medicine
|December 11, 1976
Summary
Mediastinal radiation therapy for chronic lymphocytic leukemia (CLL) showed limited efficacy, with no complete remissions. Higher radiation doses increased response rates but also severe toxicities, including fatalities.
Area of Science:
- Oncology
- Radiation Oncology
- Hematology
Background:
- Chronic lymphocytic leukemia (CLL) is a common hematologic malignancy.
- Mediastinal radiation has been explored as a treatment modality for CLL.
Purpose of the Study:
- To evaluate the efficacy and toxicity of mediastinal radiation in patients with chronic lymphocytic leukemia.
Main Methods:
- Thirty-one patients with CLL received mediastinal radiation therapy.
- Response rates and toxicity were assessed based on radiation dose and clinical outcomes.
Main Results:
- No complete remissions were achieved; 52% experienced partial remission or clinical improvement with short response duration.
- Response rates were 77% for doses >3,000 rads versus 45% for doses <3,000 rads.
- Severe, life-threatening toxicity occurred in 11 patients, leading to seven deaths.
Conclusions:
- Mediastinal radiation shows limited efficacy for CLL, with short response durations.
- Higher radiation doses correlate with improved response rates but also increased severe toxicity and mortality.
- The total radiation dose or weekly dose did not correlate with reaction severity or death.